Literature DB >> 7009447

Foot pad enlargement as a measure of induced immunity to Mycobacterium leprae.

C C Shepard, F Minagawa, R Van Landingham, L L Walker.   

Abstract

Foot pad enlargement (FPE) has been used as a measure of induced immunity to M. leprae, FPE peaked at 2-3 days, but it sometimes persisted for 4 weeks or more. Both as the inducing and eliciting antigen, heat-killed M. leprae were effective, and the optimum dose was about 1 x 10(7) bacilli. Higher doses were associated with flattening of the dose-response curve. Disrupted bacilli were not effective in immunizing mice, but they elicited FPE responses in mice immunized with intact bacilli. Cord factor was not found to have adjuvant activity for M. leprae. In immunization, the intradermal route was confirmed to be more effective than the foot pad route; the subcutaneous route was effective in providing protection against infection. FPE tests were used to investigate the steps of standard purification procedures for M. leprae in armadillo livers. A trypsin-chymotrypsin digestion step was found to be harmful to immunogenicity in one of two experiments.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7009447

Source DB:  PubMed          Journal:  Int J Lepr Other Mycobact Dis        ISSN: 0148-916X


  4 in total

1.  Enoyl-coenzyme A hydratase and antigen 85B of Mycobacterium habana are specifically recognized by antibodies in sera from leprosy patients.

Authors:  J Serafín-López; M Talavera-Paulin; J C Amador-Molina; M Alvarado-Riverón; M M Vilchis-Landeros; P Méndez-Ortega; M Fafutis-Morris; V Paredes-Cervantes; R López-Santiago; C I León; M I Guerrero; R M Ribas-Aparicio; G Mendoza-Hernández; C Carreño-Martínez; S Estrada-Parra; I Estrada-García
Journal:  Clin Vaccine Immunol       Date:  2011-05-25

2.  Induction of antigen-specific immunity and tolerance to Mycobacterium leprae in Lewis rats.

Authors:  M A Winters; R C Humphres
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

3.  Comparison of the immunogenicity of vaccines prepared from viable Mycobacterium bovis BCG, heat-killed Mycobacterium leprae, and a mixture of the two for normal and M. leprae-tolerant mice.

Authors:  C C Shepard; R M van Landingham; L L Walker; S Z Ye
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

4.  Sensitization or tolerance to Mycobacterium leprae antigen by route of injection.

Authors:  C C Shepard; L L Walker; R M Van Landingham; S Z Ye
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.